Clinical Trial Update: This Study Aims to Determine the Incidence, of Hepatitis B Diagnosis Among Diabetes Mellitus Patients of 0-80 Years of Age

View source ↗

Summary

GlaxoSmithKline-sponsored clinical trial evaluating the incidence of Hepatitis B diagnosis among diabetes mellitus patients aged 0-80 years has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Hepatitis B

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hepatitis B | Status: COMPLETED